Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Mohamed Azeem Latib

Interventional Cardiology Bronx, NY Medical Doctor

NPI 1285108910 CMS profile 6419676

111 E 210Th St, Bronx, NY 10467

Open in the dashboard

General payments

$816,294

1,203 records reported · program years 2019–2025

Research payments

$59,955

Paid to them · 12 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$3,819,421 paid to institutions, not to them · program years 2020–2025

Through program year 2025, Mohamed Azeem Latib of Bronx, NY is reported in the CMS Open Payments database as having received $816,294 across 1,203 general payments and $59,955 in research payments paid to them. Separately, studies naming them as principal investigator received $3,819,421 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Interventional Cardiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

12 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $345,934 247
2025 Research $3,284 1
2024 General $47,360 264
2024 Research $37,331 4
2023 General $48,119 160
2023 Research $7,150 2
2022 General $95,309 176
2021 General $67,412 140
2021 Research $8,450 3
2020 General $149,296 63
2019 General $62,865 153
2019 Research $3,740 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Mohamed Azeem Latib
  • Interventional Cardiology median
  • Middle half of Interventional Cardiology
  • National median

In program year 2025, general payments to Mohamed Azeem Latib were reported at $345,934. Among 6,173 Interventional Cardiology profiles paid that year, the median was $1,092 and the middle half received between $366 and $3,019.

Show as a table
Year Mohamed Azeem Latib Interventional Cardiology median Middle half National median
2019 $62,865 $1,097 $329–$3,048 $163
2020 $149,296 $473 $161–$1,480 $114
2021 $67,412 $677 $233–$1,827 $132
2022 $95,309 $978 $333–$2,724 $149
2023 $48,119 $1,136 $382–$2,986 $160
2024 $47,360 $1,181 $395–$3,326 $164
2025 $345,934 $1,092 $366–$3,019 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $299,876 85 payments
  2. Ethicon Inc. $139,782 3 payments
  3. Medtronic, Inc. $131,738 384 payments
  4. Abbott Laboratories $78,179 154 payments
  5. Medtronic Vascular, Inc. $63,366 137 payments
  6. Philips Electronics North America Corporation $41,923 39 payments
  7. Edwards Lifesciences Corporation $29,736 299 payments
  8. Ancora Heart, Inc. $12,143 13 payments
  9. Penumbra, Inc. $5,324 9 payments
  10. Centerline Biomedical Inc. $2,526 1 payment
  11. Other $11,700 79 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Acquisitions $276,437 3 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $229,379 44 payments
  3. Consulting Fee $162,130 51 payments
  4. Travel and Lodging $80,601 231 payments
  5. Food and Beverage $52,355 866 payments
  6. Grant $7,985 2 payments
  7. Honoraria $3,500 3 payments
  8. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $2,500 1 payment
  9. Compensation for serving as faculty or as a speaker for a medical education program $1,125 1 payment
  10. Long term medical supply or device loan $282 1 payment
Products named General payments · program years 2019–2025
  1. General - Therapies General - Therapies_PI $263,050 1 payment
  2. (9520) IGT Devices Undivided $40,901 28 payments
  3. NAVITOR $39,251 12 payments
  4. Resolute Stents $24,999 19 payments
  5. COREVALVE EVOLUT R $21,639 129 payments
  6. ONYX FRONTIER $20,494 30 payments
  7. Resolute Stents $19,400 26 payments
  8. General - Therapies General - Therapies_IC $15,610 13 payments
  9. CoreValve Evolut $8,769 69 payments
  10. SYMPLICITY G3 $8,692 5 payments
  11. Other $93,961 559 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Medtronic, Inc. $52,931 9 payments
  2. Medtronic Vascular, Inc. $3,740 2 payments
  3. Amgen Inc. $3,284 1 payment

Billing to Medicare

Part B · data year 2024 · 41 billing codes

Paid by Medicare

$240,072

Medicare's payments for the services billed

Medicare patients

251

Average age 80

Services billed

715

117 women, 134 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Heart failure 75%
Ischemic heart disease 75%
Atrial fibrillation 50%
Chronic kidney disease 47%
Arthritis 47%
Diabetes 40%
Cancer 29%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

1,215 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Interventional Cardiology in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record